Emerging treatment options for pancreatic cancer with Thomas Seufferlein


At the ESMO 2018 Congress (Munich, Germany, 19–23 October 2018) our Editor, Jade Parker, spoke with Thomas Seufferlein from Ulm University (Germany) about diagnostic and treatment options, his thoughts on the most significant advancements we have witnessed in the field, and emerging treatment options for pancreatic cancer – such as the TRYbeCA1 study.

View the other video in this series by clicking here

This content is supported by Erytech.